$790.740
-5.535 (-0.70%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de REGN por análisis de gráficos similares
Alphio's REGN stock price prediction model matches the current Regeneron Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $782.98 (+0.12%). The 1-week path is $762.02 (-2.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Regeneron Pharmaceuticals Inc?
Regeneron Pharmaceuticals Inc is a good buy right now, trading at $790.74 with a strong forward P/E of 14.51, indicating potential for earnings growth. The recent positive Phase 3 trial results for Pasatru highlight significant efficacy, which could drive future revenue. Additionally, hedge funds have increased their buying activity by 167% over the last quarter, suggesting strong institutional confidence. However, the RSI is at 69.33, indicating that the stock may be nearing overbought territory, which is a risk to consider.
REGN cerró en $790.74 el Friday, tras bajar -0.70%
Regeneron Pharmaceuticals Inc (REGN) last closed at $782.04, losing -1.10%. These facts feed the 1-day and 1-week REGN price prediction above.
Consenso de analistas
Regeneron Pharmaceuticals Inc (REGN): 13 comprar, 12 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Regeneron Pharmaceuticals Inc (REGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de REGN, ordenadas por similitud.
Análisis de estacionalidad de REGN
Historically the probability of a positive October return for REGN is 44.07%. August offers the highest probability of a positive month at 60.94%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de REGN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $532.77 | $606.87 | $618.10 | -22.40% |
| Nov 2026 | $582.01 | $654.23 | $691.74 | -16.34% |
| Dec 2026 | $606.44 | $711.92 | $785.14 | -8.97% |
En 2026, se proyecta que Regeneron Pharmaceuticals Inc (REGN) oscile entre $532.77 y $785.14.
Previsión mensual de Regeneron Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $606.87, con un mínimo de $532.77 y un máximo de $618.10.
En Nov de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $654.23, con un mínimo de $582.01 y un máximo de $691.74.
En Dec de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $711.92, con un mínimo de $606.44 y un máximo de $785.14.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.